Education
About Us
Working with TipRanks
Follow Us
Oncolytics Biotech (TSE:ONC)
:ONC
Earnings Data
Report Date
――
Period Ending
―Consensus EPS Forecast
―Last Year’s EPS
―Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Q
Earnings Call Date:―|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call reflects a strong positive sentiment with significant advancements in clinical data and strategic financial moves. The highlights, particularly in clinical trial progress and promising data across several cancer types, outweigh the challenges such as the ongoing CEO search and reduced R&D spending.Company Guidance
Clinical Data Exceeds Expectations
Oncolytics Biotech's clinical data for pelareorep continues to exceed expectations, particularly in difficult-to-treat malignancies such as pancreatic cancer, breast cancer, and anal carcinoma.
Positive Results in Breast Cancer Studies
Pelareorep-based combination therapy substantially outperformed standard care treatments in two randomized Phase 2 studies for HR-positive/HER2-negative metastatic breast cancer.
Promising Pancreatic and Anal Cancer Data
Interim results from the GOBLET Cohort 4 showed a 33% objective response rate in relapsed anal carcinoma, including a complete response lasting over 15 months. Additionally, the pancreatic cancer cohort is progressing with more than half of the required patients enrolled.
Favorable Safety Profile and Versatility
Pelareorep demonstrates a remarkable safety profile and versatility, showing potential in multiple cancer types and combinations with different chemotherapies and checkpoint inhibitors.
Financial Flexibility Through Share Purchase Agreement
A $20 million share purchase agreement with Alumni Capital provides Oncolytics with access to capital, enhancing financial flexibility.
Oncolytics Biotech (TSE:ONC) Earnings, Revenues Date & History
Currently, no data available
Please return soon. This page is being updated.
TSE:ONC Earnings History
Currently, no data available
Please return soon. This page is being updated.
FAQ
When does Oncolytics Biotech (TSE:ONC) report earnings?
Currently, no data Available
What is Oncolytics Biotech (TSE:ONC) earnings time?
Currently, no data Available
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:ONC EPS forecast?
Currently, no data Available